Paper22921069
Chemical perturbation of secondary metabolism demonstrates important links to primary metabolism.
Craney A and 4 others. Chem Biol, 2012. Cited by 132 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Chemical perturbation of secondary metabolism demonstrates important links to primary metabolism. Papers, record 22921069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22921069
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chemical perturbation of secondary metabolism demonstrates important links to primary metabolism.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Actinobacteria | Major topic |
| Fatty Acids | Major topic |
| Anthraquinones | |
| Anti-Bacterial Agents | |
| Chromatography, High Pressure Liquid | |
| Mass Spectrometry | |
| Prodigiosin | |
| Small Molecule Libraries | |
| Spectrophotometry | |
| Streptomyces coelicolor | |
| Benzoisochromanequinones |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MOP-57684 | Canadian Institutes of Health Research | Canada | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 22,921,060 | A magic bullet for antibiotic discovery. | https://conductscience.org/library/papers/22921060 |
Source PubMed
Cited by84
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 132 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,773,877 | Salt supplementation-induced metabolic reprogramming in Streptomyces coelicolor. | mSystems | 2026 | https://conductscience.org/library/papers/41773877 | PubMed |
| 41,364,162 | Strategies to decipher silent biosynthetic gene clusters in actinomycetes. | Arch Microbiol | 2025 | https://conductscience.org/library/papers/41364162 | PubMed |
| 39,863,791 | The genus Nocardia as a source of new antimicrobials. | NPJ Antimicrob Resist | 2025 | https://conductscience.org/library/papers/39863791 | PubMed |
| 39,824,928 | Microbial secondary metabolites: advancements to accelerate discovery towards application. | Nat Rev Microbiol | 2025 | https://conductscience.org/library/papers/39824928 | PubMed |
| 39,770,841 | The Daunomycin: Biosynthesis, Actions, and the Search for New Solutions to Enhance Production. | Microorganisms | 2024 | https://conductscience.org/library/papers/39770841 | PubMed |
| 39,629,245 | Global regulation of fungal secondary metabolism in Trichoderma reesei by the transcription factor Ypr1, as revealed by transcriptome analysis. | Eng Microbiol | 2023 | https://conductscience.org/library/papers/39629245 | PubMed |
| 39,203,402 | Impact of the Deletion of Genes of the Nitrogen Metabolism on Triacylglycerol, Cardiolipin and Actinorhodin Biosynthesis in Streptomyces coelicolor. | Microorganisms | 2024 | https://conductscience.org/library/papers/39203402 | PubMed |
| 38,999,189 | High-Throughput Mining of Novel Compounds from Known Microbes: A Boost to Natural Product Screening. | Molecules | 2024 | https://conductscience.org/library/papers/38999189 | PubMed |
| 37,627,687 | Returning to Nature for the Next Generation of Antimicrobial Therapeutics. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/37627687 | PubMed |
| 37,587,009 | Small molecule inducers of actinobacteria natural product biosynthesis. | J Ind Microbiol Biotechnol | 2023 | https://conductscience.org/library/papers/37587009 | PubMed |
| 37,176,043 | Rational Design of Daunorubicin C-14 Hydroxylase Based on the Understanding of Its Substrate-Binding Mechanism. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37176043 | PubMed |
| 36,985,733 | Rethinking Biosynthesis of Aclacinomycin A. | Molecules | 2023 | https://conductscience.org/library/papers/36985733 | PubMed |
| 36,949,330 | Optimization of FK-506 production in Streptomyces tsukubaensis by modulation of Crp-mediated regulation. | Appl Microbiol Biotechnol | 2023 | https://conductscience.org/library/papers/36949330 | PubMed |
| 36,533,629 | Fighting antibiotic resistance-strategies and (pre)clinical developments to find new antibacterials. | EMBO Rep | 2023 | https://conductscience.org/library/papers/36533629 | PubMed |
| 36,444,258 | Bioactive metabolite profile and antioxidant properties of brown juice, a processed alfalfa (Medicago sativa) by-product. | Heliyon | 2022 | https://conductscience.org/library/papers/36444258 | PubMed |
| 36,006,216 | Spaceflight Changes the Production and Bioactivity of Secondary Metabolites in Beauveria bassiana. | Toxins (Basel) | 2022 | https://conductscience.org/library/papers/36006216 | PubMed |
| 35,778,609 | Studies on Streptomyces sp. SN-593: reveromycin biosynthesis, β-carboline biomediator activating LuxR family regulator, and construction of terpenoid biosynthetic platform. | J Antibiot (Tokyo) | 2022 | https://conductscience.org/library/papers/35778609 | PubMed |
| 35,743,807 | The Impacts of Microgravity on Bacterial Metabolism. | Life (Basel) | 2022 | https://conductscience.org/library/papers/35743807 | PubMed |
| 35,608,707 | Time-related multivariate strategy for the comprehensive evaluation of microbial chemical data. | Metabolomics | 2022 | https://conductscience.org/library/papers/35608707 | PubMed |
| 35,524,050 | Inducing Global Expression of Actinobacterial Biosynthetic Gene Clusters. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/35524050 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22921069
GET https://conductscience.org/api/papers/v1/22921069/cited_by?page=2